http://www.als-mda.org/research/news/ 7/26/2010 Get the latest research news from the ALS Division of the Muscular Dystrophy Association (MDA) en-us http://alsn.mda.org/news/study-probe-oxidative-stress-people-als 07/26/2010 Participants are being sought for a 12-center study that will follow people with ALS over time to examine relationships between the disease and oxidative stress. http://alsn.mda.org/news/%E2%80%98power-journey%E2%80%99-gives-back-als-community 07/23/2010 Part support group, part fundraising effort, this group seeks to fuel ALS research while offering comfort to those who are coping with the disease. http://alsn.mda.org/news/fitness-giant-bally-goes-all-out-augie%E2%80%99s-quest 07/15/2010 Nearly 300 Bally clubs are teaming up for a two-month-long fundraiser for MDA’s Augie’s Quest research initiative. http://alsn.mda.org/news/mice-and-men-als-tdi-discusses-als-research-animals 7/6/2010 Animal models play a key role in ALS research, but their usage can be tricky, said ALS TDI in its recent public webinar. http://alsn.mda.org/news/participants-sought-three-als-trials 06/24/2010 ALS researchers are seeking participants for studies on the value of high-fat, high calorie diets; biological indicators called "biomarkers"; and the antibiotic ceftriaxone. http://www.alsn.mda.org/news/augies-new-book-extols-giving 06/16/2010 Co-Chair of MDA's ALS Division writes Reciprocity with toe-operated trackball. http://alsn.mda.org/news/flip-switch 06/15/2010 An experimental drug targets the immune system in ALS, switching cells from 'attack' to 'protective' mode. http://alsn.mda.org/news/als-ceftriaxone-trial-still-open 06/11/2010 A 600-person trial of intravenous ceftriaxone in ALS is still looking for participants at 53 North American sites. http://www.mda.org/news/100604fda-nih-mtg.html 06/04/2010 We are pleased to announce the upcoming FDA and NIH co-sponsored meeting titled Antisense Oligonucleotide (AON) Therapies in Neuromuscular Diseases, taking place on the 27th and 28th September, 2010 in Washington DC, USA. http://alsn.mda.org/news/als-tdi-changes-works 06/01/2010 ALS TDI's May 2010 research update addressed changes: a new mouse model, new projects, a paradigm shift and a model for faster drug development. http://alsn.mda.org/news/sod1-versus-other-als-apples-and-oranges 05/19/2010 New research suggests non-SOD1 familial ALS and sporadic ALS may share common features — but that SOD1 familial ALS may be different. http://quest.mda.org/news/anyones-life-story-shows-impact-als 05/03/2010 People affected by ALS share their experiences in this special MDA online feature, which runs during National ALS Awareness Month this May. http://quest.mda.org/news/luring-away-myostatin-can-boost-muscle-size 04/16/2010 Tests of the myostatin inhibitor ACE031 show the engineered protein can safely increase muscle size, a finding with potential application for many forms of neuromuscular disease. http://quest.mda.org/news/als-research-zenvia-improves-emotional-symptoms-als 04/13/2010 The experimental drug Zenvia continued to show benefit in a 12-week extension study in people with "pseudobulbar affect" (uncontrolled emotional expression). http://quest.mda.org/news/mda-study-shows-lithium-not-helpful-als 04/13/2010 Despite promising results from an Italian pilot study, follow-up trials of lithium in ALS have failed to show any benefits for the drug. http://www.als-mda.org/research/news/100408john-hopkins-als-grants.html 04/08/2010 Forty-two medical researchers and their labs have been awarded more than $21 million in grants by the Muscular Dystrophy Association to advance critical neuromuscular research in 2010. Many of the grants are multiyear awards to be dispersed over the next three years. http://quest.mda.org/news/familial-als-research-update 04/02/2010 Scientists know more about familial ALS (FALS) than sporadic ALS; FALS research may have application for both forms of the disease, however. http://quest.mda.org/news/als-research-disconnecting-immune-system 03/29/2010 ALS TDI investigators have found that disrupting part of the immune system slows disease progression in mice with an ALS-like disease http://quest.mda.org/news/health-care-changes-coming 03/23/2010 The new health care reform law has many provisions of particular interest to people with neuromuscular diseases http://quest.mda.org/news/als-sod1-trial-%E2%80%98watershed-moment%E2%80%99 03/05/2010 Human testing has begun of ISIS-SOD1-Rx, a compound designed to block production of a toxic protein in people with the SOD1-related form of familial (inherited) ALS http://quest.mda.org/news/als-tdi-full-speed-ahead 01/28/2010 ALS TDI's first-quarter 2010 research update can be summed up with one word: momentum. http://quest.mda.org/news/mda-awards-21-million-research 01/06/2010 New MDA grants recently were approved for several forms of muscular dystrophy, ALS, Friedreich's ataxia, myasthenia gravis and other diseases in MDA's program. http://www.als-mda.org/research/news/100106als-tdi-mda-partnership.html 01/06/2010 Buoyed by the extraordinary progress being made by the ALS Therapy Development Institute, the Muscular Dystrophy Association today announced a new milestone-driven grant of $2.5 million, adding to the $18 million MDA already has invested with ALS TDI - the world’s only non profit research center focused exclusively on developing treatments for amyotrophic lateral sclerosis (ALS).